1) Rabeprazole
雷贝拉唑
1.
Quadri-combination Therapy Centering on Rabeprazole Treat Positive Pylorus Spirillum Digestive Ulcer;
雷贝拉唑为主的四联疗法治疗HP阳性消化性溃疡84例体会
2.
Determination of rabeprazole at a carbon paste electrode by anodic adsorptive voltammetry;
碳糊电极阳极吸附伏安法测定雷贝拉唑
3.
Rabeprazole and Trimebutine for treatment of reflux esophagitis;
雷贝拉唑联合马来酸曲美布汀治疗反流性食管炎
2) Rebeprazole
雷贝拉唑
1.
A Comparative Evaluation of Rebeprazole and Pantoprazole in Treating Duodenal Ulcer;
雷贝拉唑与泮托拉唑治疗十二指肠溃疡的对照评价
2.
Objective:To evaluate the efficacy of rebeprazole-based triple therapy regimen contained clarithromycin and amoxicillin for the eradication of Helicobacter pylori(Hp) infection.
目的:观察雷贝拉唑联合克拉霉素和阿莫西林根除幽门螺杆菌(Hp)的临床疗效。
3.
RESULTS&CONCLUSION:Pharmacoeconomically,among the triple therapeutic schemes of Rebeprazole,Lansoprazole and Omeprazole,the scheme of Lansoprazole is the best one.
结果与结论 :从药物经济学角度看 ,在雷贝拉唑、兰索拉唑和奥美拉唑3种十二指肠溃疡三联疗法中 ,兰索拉唑三联疗法最佳。
3) rabeprazole sodium
雷贝拉唑钠
1.
The Clinical Observation of Rabeprazole Sodium in Peptic Ulcer Treatment;
雷贝拉唑钠治疗消化性溃疡的临床观察
2.
The formation and crystallization of rabeprazole sodium;
雷贝拉唑钠的成盐、结晶
3.
HPLC determination of rabeprazole sodium for injection and its related substances
HPLC法测定注射用雷贝拉唑钠的含量及有关物质
4) Rabeprazole
雷贝拉唑钠
1.
Objective To evaluate the effect and safety of Rabeprazole at the dose of 10 mg per day on peptic ulcer, comparing with omeprazole at the dose of 20 mg per day.
目的 评价雷贝拉唑钠 10mg/d在消化性溃疡治疗中的疗效及安全性 ,并与奥美拉唑 2 0mg/d进行比较。
2.
Rabeprazole is second-generation product of proton pump inhibitors (PPIs) after the producing of Omeprazole and Lanprazole.
雷贝拉唑钠是继奥美拉唑、兰索拉唑后的第二代质子泵抑制剂,广泛应用于消化系统疾病的治疗。
5) sodium rebeprazole
雷贝拉唑钠
1.
Studies on the bioequivalence of two sodium rebeprazole entric tablets in healthy volunteers;
两种雷贝拉唑钠肠溶片人体生物等效性研究
补充资料：雷贝拉唑
分子式：暂无
分子量：暂无
CAS号：117976-89-3
性质：暂无
制备方法：暂无
用途：抗溃疡病药。
分子量：暂无
CAS号：117976-89-3
性质：暂无
制备方法：暂无
用途：抗溃疡病药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条